Jim and Jeff discuss the comeback of this health-care stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
Squawk on the Street
Cramer's Morning Take: Danaher 4/23/24
Jim and Jeff discuss the comeback of this health-care stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
CNBC Investing Club Disclaimer
- Duration:
- 5m
- Broadcast on:
- 23 Apr 2024
- Audio Format:
- mp3
What's on the horizon for financial markets? At PJIM, it's a question that over 1,400 investment professionals relentlessly research in pursuit of your long-term goals. Specialised across asset classes, but united in collaboration, our teams provide global and local expertise. Our investments shape tomorrow, today. Pursue your tomorrow with PJIM, a leading global asset manager. I'm Jim Kramer, and you're about to hear a sample taken directly from today's CMC Investing Club morning meeting. We do not have a strong month except for some different companies, including, by the way, Aerospace, which is really terrific. Yeah, I'm seeing that across earnings today. I think by and large, earnings have been pretty strong, so you're getting a nice day two of a rebound after a nasty week last week. And what do you think about the fact even though Cadence was weak, we're having NASDAQ too well? Yeah, Cadence is interesting. It seems like they've been able to explain it out, but you also have yields pulling back. You did have a lot of tech stocks oversold. I mean, Nvidia down 10% last Friday. So I was putting together a couple of good days in a row, and we were coming into the day still slightly oversold, according to the oscillator. Not as much oversold as we were, say, the last couple of days, but you mentioned a week March, and I think it's worth flagging here. You did have yields initially higher this morning, but then they started to move lower after S&P Global PMI, much weaker than expected. Right. Manufacturing under 50. Big focus. Now remember, we added that two year today. It's under five. Big two-year auction. I got one. Yeah, I put in to get it, because I thought it was going to be five. Right now, it's not looking five, which is really pretty amazing. And don't forget, we have this three-year that Rick Sintali is constantly talking about. It's really, really big. It's a gauntlet that we have to get through. There's no doubt about it. Absolutely. But if we have companies that are doing okay, but not raising price, remember, Proctor put through price, had cost go down, had big margin. PepsiCo could not put through price, costs stayed the same, voila, stock is clap. Yeah. That's the consistency that we're always trying to judge with consumer companies. It's why we like Proctor, because the volumes were improving. Right. It's why we've liked Constellation Brands, because that's a volume driven story. But I do want to get back to earnings real quick for today. Sure. Danher, one of the top gainers in the market, a very clean beat, bioprocessing, getting closer to that inflection. He had a 21 cent earnings beat, revenues better than expected. Keyline in the press release really sent the stock off was Q1 orders increased mid-single digits, sequentially from Q4. People were looking forward to Cline, so that's a true upside surprise. Now, with the bell getting a little bit better, still slightly under one. But I would point out that when we have stocks up this much, you get a great second day, which is really rather extraordinary, because you think the stock of $15 has no ammo to go a second day. The reason why it goes up a second day is because all the guys who are bears come out and realize they better get on the Danher train. So you have a second day rally. Yeah. Especially with inventory normalizing. Imagine we're only talking about the funding environment improving, we've been pointing that out with all the biotech deals that have been happening. And there's many coming. Yeah. And they said that's a positive indicator for the future. Start your day with my outlook on the daily market every morning at 10 20 a.m. Visit cmbc.com/morningtake to access all the benefits of being a CMBC investing club at Denver, all opinions expressed by Jim Kramer on this podcast and in connection with the CNBC investing club are solely Kramer's opinions and do not reflect the opinions of CNBC, NBC, Universal, or their parent company or affiliates and may have been previously disseminated by Kramer on television, radio, internet or another medium. No specific outcome or profit is guaranteed in connection with your reliance upon or other use of the content from Kramer. The opinions offered in connection with this podcast and the CNBC investing club are not an attempt to induce any particular trading behavior, investment or strategy. You should be aware of the risk of loss in following any strategy or investment discussed in the content from Kramer. To view the full CNBC investing club disclaimer, please visit cmbc.com/investingclubdisclaimer. The spirit of performance defines Acura and now it's electric, introducing the all-electric ZVX, Acura's most powerful SUV yet. While what powers their cars may change, the energy that makes Acura never will, crafted using the same formula that brought them electrified supercars and multiple MSA championships, the ZVX has tracked tested performance that packs an energy all its own. With a premium bang and olives and sound system and up to 313 mile range on a single charge and a type S variant with an estimated 500 horsepower, the ZVX is everything they said electric could never be. It was built with the driver in mind, just like Acura has been doing since the beginning. We could talk all day, but the only way to experience this electric performance is to drive it yourself. Unlock the energy and order yours at Acura.com. [BLANK_AUDIO]